The 25th International Symposium on Radiopharmaceutical Sciences was held in May 2023 in Hawaii. Abstract papers of Mortenon M1 were presented at the conference in the form of Poster presentations, attracted many countries and regional customers to stop and consult.

M1 Poster Display Location: P-294

This paper introduces the development and application of M1 type nuclide multifunctional synthesis module (hereinafter referred to as M1), and expounds its design principle and control program.

The above picture shows a group photo of Professor Zheng Qihuang (first from the right, poster speaker) from Indiana University School of Medicine and Dr. Wu Weisi (first from the left), Chief Technology Officer of Noyu Pharmaceuticals, who was invited to participate in the exhibition



Professor Zheng engaged in enthusiastic discussions with attendees interested in the M1 Poster.
 

In recent years, radiopharmaceuticals have shown strong clinical potential, and the clinical demand for nuclear drugs has shown an obvious upward trend. At present, the manual preparation commonly used in the production of nuclear drugs no longer meets the needs of nuclear drug preparation, especially the demand for high-dose production of nuclear drugs at the enterprise level.

His automated production line is designed and built by the senior R&D team of Sunmao with the advantages of highly mastering the industrial process of automated nuclear drug production. Mortenon M1, a multi-functional synthesis module independently developed by Sunmao Medical, can be remotely operated under software control to achieve automatic radiolabeling of small molecules, peptides and antibody drugs, and has the functions of solid target nuclide separation and purification, automatic packaging of nuclides and waste gas treatment. This integrated function is the first in the world.

It has an innovative combined design, only occupy a hot sell space to carry out solid target nuclide separation and purification, radiopharmology synthesis work, through the rapid replacement of the casette, can achieve solid target nuclide purification + antibody drug preparation within 3 hours. Automated workflow design, the realization of one-click synthesis of nuclear drugs, and remote real-time tracking of synthesis status, reduce the threshold of operation and the exposure to nuclides, and achieve the standardization and homogenization of nuclear drug production, become a useful automated helper for customers.

The conference invited four world-renowned experts to give keynote reports, and many world-renowned experts in the field of radiopharmaceuticals, isotopes and labeled compounds, and nuclear medicine to give special reports.

Sunmao Medical hopes to exchange ideas with the participants through the world-class window, mutual learning results, and further promote their own innovative development. At the same time, Sunmao is working hard to continue to launch more new products of nuclear medicine automation equipment, contributing to the upgrading of global nuclear medicine infrastructure.